Medications for Diabetes

Size: px
Start display at page:

Download "Medications for Diabetes"

Transcription

1 Medications for Diabetes Sweet, but not too sweet Colette Raymond, Pharm D June 15, 2011

2 Learning Objectives At the end of this presentation you should be able to: Understand the prevalence and types of diabetes. Understand that uncontrolled diabetes can lead to serious long-term complications. Recognize the differences between medications used to treat diabetes.

3 What is Diabetes?

4 What is diabetes?

5 Risk Factors for Diabetes Canadian Diabetes Guidelines 2008

6

7 Diagnosis A fasting blood glucose (no food or drink, at least 8 hours pre) test > 7.0 mmol/l suggests diabetes. Patients with a fasting blood glucose of 6.0 to 7.0 mmol/l are at high risk of developing diabetes in the future.

8 Diabetes in Manitoba Surveillance Report 2009

9 Complications of diabetes

10 Big vessels Diabetic complications Heart attacks, strokes 80% of people with DM will die of a vascular event! (Diabetes Care 2003;27(Suppl2):S58) Small vessels Kidneys Nerves (feet) Eyes 68% of people with DM do NOT think that CVD is a complication of DM! (J Am Coll Cardiol 2002;40:1877)

11 COMPLICATIO NS OF DIABETES Vision Loss Skin Problems Foot Care Kidney Disease Heart Disease and Stroke COMMENTS Diabetic retinopathy is the most common cause of blindness in people under age 65 High blood glucose lowers resistance to infections and slows healing of skin Over time, diabetes can damage sensory nerves in the hands and feet (i.e. neuropathy) leaving patients less likely to feel a foot injury Left unnoticed, these injuries can become infected and potentially lead to serious complications Risk factors: High blood glucose and blood pressure About one-third of people who have had diabetes for more than 15 years will develop kidney disease Diabetics may develop heart disease 10 to 12 years earlier than individuals w/o diabetes Up to 80% of people with diabetes will die from a heart attack or stroke

12 Complications of diabetes

13 Treatment of diabetes

14 Treatment of Diabetes Education Physical Activity Nutrition Weight Management Medication Lifestyle Management Blood Pressure Control

15 Treatment of diabetes: Non blood sugar targets Condition Target Lipids LDL <2.0mmol/L BP <130/80 Smoking Weight loss (if BMI > 30) None! 5-10% Lifestyle modification for all! Canadian Diabetes Guidelines 2008

16 Goals of therapy: glycemic control Target for most patients Recommended targets for glycemic control A1C (%) FPG (mmol/l) 2 hr postprandial (mmol/l) < Normal < Goal to obtain target A1C within 6-12 mo Manitoba Diabetes Care Recommendations 2010, Canadian Diabetes Guidelines 2008

17 Drugs for diabetes Metformin Glyburide, gliclazide Rosiglitazone (Avandia), Pioglitazone (Actos) Repaglinide (Gluconorm) Acarbose (Glucobay) Insulin 30/70, NPH, N, Toronto, Regular

18 Mechanism of oral agents Metformin X Decrease glucose production Alphaglucosidase inhibitor BETTER GLUCOSE CONTROL Slow glucose absorption Sulfonlyureas Meglitinides Increase insulin production Increase insulin sensitivity Glitazones (Metformin)

19 Oral Agents comparison JAMA 2002;287: Monotherapy only practical when A1C 8 % Decrease in A1C (%) across trials Sulfonylureas Meglitinides Metformin Glitazones Acarbose

20 Management of hyperglycemia in type 2 diabetes Add another agent best suited to the patient CDA 2008

21 Management of hyperglycemia in type 2 diabetes CDA 2008

22 Insulin Therapy Insulin preparations differ by their duration of action, time of onset and peak actions. Available in rapid, short, intermediate, and longacting preparations.

23 Category Insulin Colour Onset Peak Duration Rapid Acting Lispro (Humalog) Aspart (Novorapid) Clear hrs mins hr 3-6 h Short Acting Humulin R Novolin Toronto Clear hr 2-5 h 6-8 h Intermediate acting Humulin / N Novolin NPH Cloudy 1-2 h 4-12 h h Long acting Detemir (Levemir) Clear (Don t mix) Dose dependent 1-2 h Peakless Dose dependent hrs Glargine (Lantus) Clear (Don t mix) 1.5 h Peakless 24 h Humalog Mix 25 Mixed Humulin 20/80, 30/70 Novolin 10/90, 20/80, 30/70, 40/60, 50/50 Cloudy h 2-12 (Dual peak) h

24

25 Side effects: diabetes drugs Metformin, Acarbose (Glucobay) Stomach Start low, go slow Rosiglitazone (Avandia), Pioglitazone (Actos) Puffiness, swelling Glyburide, gliclazide, Insulin, Repaglinide (Gluconorm) low blood sugar learn how to manage, decrease dose, switch from glyburide to others Weight gain importance of diet

26 Side effects of drugs for diabetes Low blood sugar

27 How to manage low blood sugar 3 glucose tablets (15 grams glucose) PO OR ¾ cup of juice * OR 3 tsp (3 packs) of sugar dissolved in water Then retest, Have snack** of 1 starch and 1 protein ** Snack Examples: 1 piece of bread/ toast with peanut butter, 8 crackers with cheese, ½ sandwich

28

What the Pill Looks Like. How it Works. Slows carbohydrate absorption. Reduces amount of sugar made by the liver. Increases release of insulin

What the Pill Looks Like. How it Works. Slows carbohydrate absorption. Reduces amount of sugar made by the liver. Increases release of insulin Diabetes s Oral s - Pills These are some of the pills that are currently available in Canada to treat diabetes. Each medication has benefits and side effects you should be aware of. Your diabetes team

More information

Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery

Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery Girish P. Joshi, MB BS, MD, FFARCSI Anesthesia & Analgesia

More information

TABLE 1A : Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations

TABLE 1A : Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations 177 TABLE 1A : Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations Formulary Coverage Indication for use with: INSULIN THERAPY NS NB NL PE ADULTS PEDIATRICS PREGNANCY BOLUS

More information

TABLE 1A: Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations

TABLE 1A: Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations 177 TABLE 1A: Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations TABLE 1A : Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations Formulary

More information

Diabetes Basics. Type 1 diabetes The body cannot make insulin Requires insulin injection Is not treated with oral diabetes medicines (pills)

Diabetes Basics. Type 1 diabetes The body cannot make insulin Requires insulin injection Is not treated with oral diabetes medicines (pills) Diabetes Basics What is Diabetes? Diabetes is a disease in which the pancreas is unable to make insulin or the body is unable to use insulin or both. This leads to high blood sugar levels in the blood.

More information

Comprehensive Diabetes Treatment

Comprehensive Diabetes Treatment Comprehensive Diabetes Treatment Joshua L. Cohen, M.D., F.A.C.P. Professor of Medicine Interim Director, Division of Endocrinology & Metabolism The George Washington University School of Medicine Diabetes

More information

I. General Considerations

I. General Considerations 1 2 3 I. General Considerations A. Type I ( Juvenile Onset or IDDM) IDDM results from autoimmune destruction of beta cells inability to secrete insulin --> ketone formation --> DKA 4 Diabetic Ketoacidosis

More information

PHARMACISTS INTERACTIVE EDUCATION CASE STUDIES

PHARMACISTS INTERACTIVE EDUCATION CASE STUDIES PHARMACISTS INTERACTIVE EDUCATION CASE STUDIES Disclaimer: The information in this document is not a substitute for clinical judgment in the care of a particular patient. CADTH is not liable for any damages

More information

In-Hospital Management of Diabetes. Dr Benjamin Schiff Assistant Professor McGill University

In-Hospital Management of Diabetes. Dr Benjamin Schiff Assistant Professor McGill University In-Hospital Management of Diabetes Dr Benjamin Schiff Assistant Professor McGill University No conflict of interest to declare CLINICAL SCENARIO 62 y/o male with hx of DM 2, COPD, and HT is admitted with

More information

Table 1. Antihyperglycemic agents for use in type 2 diabetes

Table 1. Antihyperglycemic agents for use in type 2 diabetes Table 1. Antihyperglycemic agents for use in type 2 diabetes DRUG IN ALPHA-GLUCOSIDASE INHIBITOR: inhibits pancreatic alpha-amyle and intestinal alpha-glucoside Acarbose (Glucobay) 0.6% Negligible Not

More information

Choosing a Diabetes Strategy Where to Start and Where to Go

Choosing a Diabetes Strategy Where to Start and Where to Go Choosing a Diabetes Strategy Where to Start and Where to Go Erin Keely, MD, FRCPC; and Sharon Brez, RN, BScN, MA(Ed), CDE As presented at the University of Ottawa's 52nd Annual Refresher Course for Family

More information

PHARMACISTS INTERACTIVE EDUCATION CASE STUDIES

PHARMACISTS INTERACTIVE EDUCATION CASE STUDIES PHARMACISTS INTERACTIVE EDUCATION CASE STUDIES Disclaimer: The information in this document is not a substitute for clinical judgment in the care of a particular patient. CADTH is not liable for any damages

More information

Diabetes Head to Toe May 31, 2017

Diabetes Head to Toe May 31, 2017 Innovations in Insulin Joanne Reid RN CDE jmreid@gbhs.on.ca Danielle Benedict RPh Outline Setting the stage Insulin as pancreas replacement therapy Commonly used insulins New insulins Case Studies Dosing

More information

Type I Type II Insulin Resistance

Type I Type II Insulin Resistance Insulin An aqueous hormonal solution made in the pancreas. Affects metabolism by allowing glucose to leave the blood and enter the body cells, preventing hyperglycemia. It is measured in units, e.g. 100

More information

第十五章. Diabetes Mellitus

第十五章. Diabetes Mellitus Diabetes-1/9 第十五章 Diabetes Mellitus 陳曉蓮醫師 2/9 - Diabetes 羅東博愛醫院 Management of Diabetes mellitus A. DEFINITION OF DIABETES MELLITUS Diabetes Mellitus is characterized by chronic hyperglycemia with disturbances

More information

Diabetes in Pregnancy

Diabetes in Pregnancy Diabetes in Pregnancy Ebony Boyce Carter, MD, MPH Division of Maternal Fetal Medicine Washington University School of Medicine Disclosures I have no financial disclosures to report. Objectives Review the

More information

Mae Sheikh-Ali, M.D. Assistant Professor of Medicine Division of Endocrinology University of Florida College of Medicine- Jacksonville

Mae Sheikh-Ali, M.D. Assistant Professor of Medicine Division of Endocrinology University of Florida College of Medicine- Jacksonville Mae Sheikh-Ali, M.D. Assistant Professor of Medicine Division of Endocrinology University of Florida College of Medicine- Jacksonville Pathogenesis of Diabetes Mellitus (DM) Criteria for the diagnosis

More information

Objectives. How Medicine Works to Control Blood Sugar Levels. What Happens When We Eat? What is diabetes? High Blood Glucose (Hyperglycemia)

Objectives. How Medicine Works to Control Blood Sugar Levels. What Happens When We Eat? What is diabetes? High Blood Glucose (Hyperglycemia) How Medicine Works to Control Blood Sugar Levels Stacie Petersen, RN, CDE Objectives Define Diabetes List how medications work (ominous octet) Identify side effects of medications for diabetes What is

More information

Diabetes: What You Need to Know

Diabetes: What You Need to Know UW MEDICINE PATIENT EDUCATION Diabetes: What You Need to Know Discharge review before you leave the hospital We want to be sure that we explained your diabetes instructions well, so that you know how to

More information

How to Fight Diabetes and Win. Diabetes. Medications

How to Fight Diabetes and Win. Diabetes. Medications How to Fight Diabetes and Win Diabetes Medications MEDICATIONS FOR DIABETES According to the American Diabetes Association, 85% of adults diagnosed with diabetes take insulin and/or oral medication to

More information

24 Hour Support. Telephone Available 24 hours a day, 7 days a week

24 Hour Support. Telephone Available 24 hours a day, 7 days a week Contents Page What is SHAIRE? 1 What is basal-bolus regimen? 2 Why do I need a basal-bolus regimen? 3 How does basal insulin work? 3 How does rapid-acting insulin work? 4 How often should I test my Blood

More information

Premixed Insulin for Type 2 Diabetes. a gu i d e f o r a d u lt s

Premixed Insulin for Type 2 Diabetes. a gu i d e f o r a d u lt s Premixed Insulin for Type 2 Diabetes a gu i d e f o r a d u lt s March 2009 What This Guide Covers / 2 Type 2 Diabetes / 3 Learning About Blood Sugar / 4 Learning About Insulin / 5 Comparing Medicines

More information

Blood Sugar and Insulin

Blood Sugar and Insulin PATIENT & CAREGIVER EDUCATION Blood Sugar and Insulin This information explains high and low blood sugar levels and how to manage them. About Blood Sugar and Insulin Your body uses a sugar called glucose

More information

The York Diabetes Care Model

The York Diabetes Care Model This Session The York Diabetes Care Model The annual review what s it for and how to do it How to make the diagnosis of diabetes and who to test Categorisation of diabetes at diagnosis Basics of Insulin

More information

Diabetes Overview. Basics of Diabetes

Diabetes Overview. Basics of Diabetes Diabetes Overview Basics of Diabetes Objectives Review the prevalence of diabetes, how it develops and the risk of developing diabetes Review diabetes diagnosis Identify the key areas of medically managing

More information

RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES

RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES Risk Factors or Complications Glycemic Control Fasting & Capillary Plasma Glucose Anti-platelet

More information

Diabetes Management in New Brunswick Nursing Homes

Diabetes Management in New Brunswick Nursing Homes Diabetes Management in New Brunswick Nursing Homes Prepared by Dr. Angela McGibbon March, 2016 As the population ages and with the rising incidence of diabetes, there are increasing numbers of people with

More information

Tips and Tricks for Starting and Adjusting Insulin. MC MacSween The Moncton Hospital

Tips and Tricks for Starting and Adjusting Insulin. MC MacSween The Moncton Hospital Tips and Tricks for Starting and Adjusting Insulin MC MacSween The Moncton Hospital Progression of type 2 diabetes Beta cell apoptosis Natural History of Type 2 Diabetes The Burden of Treatment Failure

More information

Type 2 Diabetes: Where Do We Start with Treatment? DIABETES EDUCATION. Diabetes Mellitus: Complications and Co-Morbid Conditions

Type 2 Diabetes: Where Do We Start with Treatment? DIABETES EDUCATION. Diabetes Mellitus: Complications and Co-Morbid Conditions Diabetes Mellitus: Complications and Co-Morbid Conditions ADA Guidelines for Glycemic Control: 2016 Retinopathy Between 2005-2008, 28.5% of patients with diabetes 40 years and older diagnosed with diabetic

More information

Diabetes education material. 1. Fasting plasma glucose (FPG) (No caloric intake for at least 8 hours)

Diabetes education material. 1. Fasting plasma glucose (FPG) (No caloric intake for at least 8 hours) How do I assess plasma glucose control? Diabetes education material There are four different ways to assess plasma glucose control: 1. Fasting plasma glucose (FPG) (No caloric intake for at least 8 hours)

More information

Glyceamic control is indicated by 1. Fasting blood sugar less than 126 mg/dl 2. Random blood sugar 3. HbA1c less than 6.5 % Good glycaemic control

Glyceamic control is indicated by 1. Fasting blood sugar less than 126 mg/dl 2. Random blood sugar 3. HbA1c less than 6.5 % Good glycaemic control Glyceamic control is indicated by 1. Fasting blood sugar less than 126 mg/dl 2. Random blood sugar 3. HbA1c less than 6.5 % Good glycaemic control can prevent many of early type 1 DM(in DCCT trail ). UK

More information

Diabetes Basics - The who, what, why, and how of diabetes care

Diabetes Basics - The who, what, why, and how of diabetes care Diabetes Basics - The who, what, why, and how of diabetes care Garrett Huxall Pharm.D, CGP,FASCP Consultant Pharmacist PharmCare/Deer Creek Consulting Objectives Understand what diabetes is and the complications

More information

Objectives 2/13/2013. Figuring out the dose. Sub Optimal Glycemic Control: Moving to the Appropriate Treatment

Objectives 2/13/2013. Figuring out the dose. Sub Optimal Glycemic Control: Moving to the Appropriate Treatment Sub Optimal Glycemic Control: Moving to the Appropriate Treatment Judy Thomas, MSN, FNP-BC Holt and Walton, Rheumatology and Endocrinology Objectives Upon completion of this session you will be better

More information

Management of Type 2 Diabetes. Why Do We Bother to Achieve Good Control in DM2. Insulin Secretion. The Importance of BP and Glucose Control

Management of Type 2 Diabetes. Why Do We Bother to Achieve Good Control in DM2. Insulin Secretion. The Importance of BP and Glucose Control Insulin Secretion Management of Type 2 Diabetes DG van Zyl Why Do We Bother to Achieve Good Control in DM2 % reduction 0-5 -10-15 -20-25 -30-35 -40 The Importance of BP and Glucose Control Effects of tight

More information

Management of Diabetes New Concepts New Devices New Medications. Richard J. Comi, MD Professor of Medicine Geisel School of Medicine at Dartmouth

Management of Diabetes New Concepts New Devices New Medications. Richard J. Comi, MD Professor of Medicine Geisel School of Medicine at Dartmouth Management of Diabetes New Concepts New Devices New Medications Richard J. Comi, MD Professor of Medicine Geisel School of Medicine at Dartmouth Objectives: At the end of this lecture, the learner will

More information

Diabetes: Everything You Want to Know. LCDR Bernadine John, RN, BSN, CDE

Diabetes: Everything You Want to Know. LCDR Bernadine John, RN, BSN, CDE Diabetes: Everything You Want to Know LCDR Bernadine John, RN, BSN, CDE I have no financial affiliation to disclose as a conflict of interest regarding this presentation. DM Standards of Care The IHS Division

More information

Let Them Eat Cake Clinical Practice Recommendations for Diabetes Management

Let Them Eat Cake Clinical Practice Recommendations for Diabetes Management Let Them Eat Cake Clinical Practice Recommendations for Diabetes Management Mimi Cunningham, MA, RDN, CDE Idaho Health Care Association 2015 Winter Workshop Goals You Go Home With Confidence in your knowledge

More information

Information for Patients

Information for Patients Information for Patients Guidance for Diabetic Persons having an OGD or Bronchoscopy This guidance is provided to assist with your preparation for your endoscopic procedure. If you feel unclear about how

More information

Wayne Gravois, MD August 6, 2017

Wayne Gravois, MD August 6, 2017 Wayne Gravois, MD August 6, 2017 Americans with Diabetes (Millions) 40 30 Source: National Diabetes Statistics Report, 2011, 2017 Millions 20 10 0 1980 2009 2015 2007 - $174 Billion 2015 - $245 Billion

More information

Antihyperglycemic Agents in Diabetes. Jamie Messenger, PharmD, CPP Department of Family Medicine East Carolina University August 18, 2014

Antihyperglycemic Agents in Diabetes. Jamie Messenger, PharmD, CPP Department of Family Medicine East Carolina University August 18, 2014 Antihyperglycemic Agents in Diabetes Jamie Messenger, PharmD, CPP Department of Family Medicine East Carolina University August 18, 2014 Objectives Review 2014 ADA Standards of Medical Care in DM as they

More information

DIABETES. overview of pharmacologic agents used in the management of. Overview 4/3/2014 OBJECTIVES. Injectable Agents

DIABETES. overview of pharmacologic agents used in the management of. Overview 4/3/2014 OBJECTIVES. Injectable Agents overview of pharmacologic agents used in the management of DIABETES Kyle Roberts, Pharm.D. PGY-1 Pharmacy Resident Saint Alphonsus RMC 1. List the different classes of diabetes medications, including the

More information

Type 2 Diabetes Mellitus 2011

Type 2 Diabetes Mellitus 2011 2011 Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Michael.mcdermott@ucdenver.edu Diabetes Mellitus Diagnosis 2011 Diabetes Mellitus Fasting Glucose

More information

Get Healthy Stay Healthy

Get Healthy Stay Healthy Diabetes Management WHAT IS DIABETES? Diabetes is a lifelong disease. It is a defect in your body s ability to convert glucose (sugar) to energy. Diabetes develops when your pancreas does not produce enough

More information

Clinical Cases in Diabetes Management. Joseph Cook D.O.

Clinical Cases in Diabetes Management. Joseph Cook D.O. Clinical Cases in Diabetes Management Joseph Cook D.O. Objectives State the prevalence of Diabetes Mellitus in Ohio State the percentage of diabetic patients in the U.S. treated by Primary Care Physicians

More information

Very Practical Tips for Managing Type 2 Diabetes

Very Practical Tips for Managing Type 2 Diabetes Very Practical Tips for Managing Type 2 Diabetes Jean-François Yale, MD, FRCPC McGill University Health Centre, Montreal, Canada Jean-francois.yale@mcgill.ca www.dryale.ca OBJECTIVES DISCLOSURES The participant

More information

Diabetes School October 2016

Diabetes School October 2016 Diabetes School October 2016 Name Change- Why? Shorter Has my name in it Emphasizes a major part of the practice Still see non-research patients Novo Nordisk Lilly sanofi aventis! Thank You to our LucasResearch

More information

Mixed Insulins Pick Me

Mixed Insulins Pick Me Mixed Insulins Pick Me Alvin Goo, PharmD Clinical Associate Professor University of Washington School of Pharmacy and Department of Family Medicine Objectives Critically evaluate the evidence comparing

More information

Adjusting Your Diabetes Medicine and Diet for a Test or Procedure

Adjusting Your Diabetes Medicine and Diet for a Test or Procedure health information Adjusting Your Diabetes Medicine and Diet for a Test or Procedure The guidelines below will help you adjust your diabetes medicine and diet as you get ready for your procedure or lab

More information

Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone

Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone Index Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone Medication GAD glutamic acid decarboxylase GLP-1 glucagon-like peptide 1 NPH neutral

More information

Objectives. Recognize all available medical treatment options for diabetes. Individualize treatment and glycemic target based on patient factors

Objectives. Recognize all available medical treatment options for diabetes. Individualize treatment and glycemic target based on patient factors No disclosure Objectives Recognize all available medical treatment options for diabetes Individualize treatment and glycemic target based on patient factors Should be able to switch to more affordable

More information

Diabetes mellitus. Treatment

Diabetes mellitus. Treatment Diabetes mellitus Treatment Recommended glycemic targets for the clinical management of diabetes(ada) Fasting glycemia: 80-110 mg/dl Postprandial : 100-145 mg/dl HbA1c: < 6,5 % Total cholesterol: < 200

More information

Diabetes Mellitus. Raja Nursing Instructor. Acknowledgement: Badil 09/03/2016

Diabetes Mellitus. Raja Nursing Instructor. Acknowledgement: Badil 09/03/2016 Diabetes Mellitus Raja Nursing Instructor 09/03/2016 Acknowledgement: Badil Objective: Define Diabetes Mellitus (DM) & types of DM. Understand the pathophysiology of Type-I & II DM. List the clinical features

More information

LET S TALK INSULIN THE BASICS

LET S TALK INSULIN THE BASICS LET S TALK INSULIN THE BASICS AUTHOR S DISCLOSURES Contracted for program development for Lifescan Canada Speaker for Lifescan, Lilly, BI, Consultant for Lilly, Janssen, Novo Nordisk, Lifescan Canada OBJECTIVES

More information

Basal Bolus Insulin Therapy Frequently Asked Questions

Basal Bolus Insulin Therapy Frequently Asked Questions 1. What is Basal Bolus Insulin Therapy (BBIT)? 2. What evidence supports the use of subcutaneous Basal Bolus Insulin Therapy? 3. Does Basal Bolus Insulin Therapy apply to all patients? 4. What s wrong

More information

Type 2 Diabetes Mellitus Insulin Therapy 2012

Type 2 Diabetes Mellitus Insulin Therapy 2012 Type 2 Diabetes Mellitus Therapy 2012 Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Michael.mcdermott@ucdenver.edu Preparations Onset Peak Duration

More information

Diabetes Mellitus Type 2

Diabetes Mellitus Type 2 Diabetes Mellitus Type 2 What is it? Diabetes is a common health problem in the U.S. and the world. In diabetes, the body does not use the food it digests well. It is hard for the body to use carbohydrates

More information

Diabetes Treatment Update

Diabetes Treatment Update Diabetes Treatment Update Timothy C. Evans, MD PhD FACP University of Washington Department of Medicine Disclosure: Dr. Evans has no significant financial interest in any of the products or manufacturers

More information

Rhonda Eustice, PharmD, CDE. Will Power lasts about two weeks and is soluble in alcohol. Mark Twain

Rhonda Eustice, PharmD, CDE. Will Power lasts about two weeks and is soluble in alcohol. Mark Twain Rhonda Eustice, PharmD, CDE Will Power lasts about two weeks and is soluble in alcohol. Mark Twain Diabetes Management: The Three Legged Stool Diet Medication Exercise Objectives Know the treatment goals

More information

Insulin Prior Authorization with optional Quantity Limit Program Summary

Insulin Prior Authorization with optional Quantity Limit Program Summary Insulin Prior Authorization with optional Quantity Limit Program Summary 1-13,16-19, 20 FDA LABELED INDICATIONS Rapid-Acting Insulins Humalog (insulin lispro) NovoLog (insulin aspart) Apidra (insulin glulisine)

More information

Current Trends in Diagnosis and Management of Gestational Diabetes

Current Trends in Diagnosis and Management of Gestational Diabetes Current Trends in Diagnosis and Management of Gestational Diabetes Shreela Mishra, MD Assistant Clinical Professor UCSF Fresno Medical Education Program 2/2/2019 Disclosures No disclosures 2/2/19 Objectives

More information

Understanding Diabetes and Insulin Delivery Systems

Understanding Diabetes and Insulin Delivery Systems Page 1 This program has been supported by an educational grant from Sanofi Aventis Scott K. Stolte, Pharm.D. Associate Dean, Academic Affairs Bernard J. Dunn School of Pharmacy Shenandoah University Winchester,

More information

5/21/2013. Welcome. Today. Facts about Diabetes. Living Well with Diabetes Including: Physical Activity. Learn about diabetes and how to manage it

5/21/2013. Welcome. Today. Facts about Diabetes. Living Well with Diabetes Including: Physical Activity. Learn about diabetes and how to manage it Welcome Living Well with Diabetes Including: Physical Activity Today. Learn about diabetes and how to manage it If you or your client have medical questions about diabetes, talk with their doctor, healthcare

More information

The Diabetes Guidelines Trek: The Next Generation. Inpatient Diabetes Guidelines. Learning Objectives. Current Inpatient Guidelines

The Diabetes Guidelines Trek: The Next Generation. Inpatient Diabetes Guidelines. Learning Objectives. Current Inpatient Guidelines The Diabetes Guidelines Trek: The Next Generation J. Christopher Lynch, PharmD, BCACP Southern Illinois University Edwardsville School of Pharmacy Susan Cornell BS, PharmD, CDE, FAPhA, FAADE Midwestern

More information

The information in this guide comes from a government-funded review of research about pills for type 2 diabetes.

The information in this guide comes from a government-funded review of research about pills for type 2 diabetes. effectivehealthcare.ahrq.gov Pills for Type 2 Diabetes: A Guide for Adults Consumer Summary Guide published 5 Dec 2007 1. Introduction What does this guide cover? Type 2 diabetes means the body has a problem

More information

AACN PCCN Review. Endocrine

AACN PCCN Review. Endocrine AACN PCCN Review Endocrine Presenter: Carol A. Rauen, RN, MS, CCNS, CCRN, PCCN, CEN Independent Clinical Nurse Specialist & Education Consultant rauen.carol104@gmail.com Endocrine I. INTRODUCTION Disorders

More information

Diabetes Management: A diagnostic perspective

Diabetes Management: A diagnostic perspective Diabetes Management: A diagnostic perspective Images: http://www.engadget.com/2009/09/23/bayer-introduces-countour-usb-glucose-meter/ http://www.medtronicdiabetes.com/treatment-and-products/minimed-530g-diabetes-system-with-enlite

More information

Oral and Injectable Non-insulin Antihyperglycemic Agents

Oral and Injectable Non-insulin Antihyperglycemic Agents Appendix 5: Diabetes Education and Medical Management in Adults with Diabetes Oral and Injectable Non-insulin s This directive will be implemented by RPhs, RNs or RDs who have been deemed authorized implementers.

More information

Insulin Basics. Bryan Primary Care Conference May 21, 2016 Shannon Wakeley MD Complete Endocrinology

Insulin Basics. Bryan Primary Care Conference May 21, 2016 Shannon Wakeley MD Complete Endocrinology Insulin Basics Bryan Primary Care Conference May 21, 2016 Shannon Wakeley MD Complete Endocrinology Disclosures Speakers Bureau for Sanofi, Astra Zeneca, Janssen, Boehringer-Ingelheim Objectives Discuss

More information

Canadian Diabetes Association 2013

Canadian Diabetes Association 2013 Spring 2014 Canadian Diabetes Association 2013 clinical practice guidelines - Do claims data align to the guidelines? Canadian Diabetes Association 2013 clinical practice guidelines - Do claims data align

More information

What s New in Type 1 and Type 2 Diabetes? Updates from 2013 CDA CPGs and Advancements in Insulin Therapy

What s New in Type 1 and Type 2 Diabetes? Updates from 2013 CDA CPGs and Advancements in Insulin Therapy What s New in Type 1 and Type 2 Diabetes? Updates from 2013 CDA CPGs and Advancements in Insulin Therapy 2013 Rocky Mountain/ACP Internal Medicine Conference November 15, 2013 David C.W. Lau, MD, PhD,

More information

CE on SUNDAY Miami, FL May 31, 2009

CE on SUNDAY Miami, FL May 31, 2009 CE on SUNDAY Miami, FL May 31, 2009 Date: Sunday, May 31, 2009 Time: 1:15 PM 2:15 PM Location: Doubletree Miami Mart/Airport Hotel Title: Speaker(s): Understanding Diabetes and Insulin Delivery Systems

More information

Diabetes. What you need to know

Diabetes. What you need to know Diabetes What you need to know Please visit the UHN Patient Education website for more health information: www.uhnpatienteducation.ca 2016 University Health Network. All rights reserved. This information

More information

Quick Reference Guide

Quick Reference Guide 2018 Clinical Practice Guidelines Quick Reference Guide 416569-18 guidelines.diabetes.ca diabetes.ca 1-800-BANTING (226-8464) Screening and Diagnosis Assess risk ANNUALLY if: Family history (First-degree

More information

Insulin Initiation, titration & Insulin switch in the Primary Care-KISS

Insulin Initiation, titration & Insulin switch in the Primary Care-KISS Insulin Initiation, titration & Insulin switch in the Primary Care-KISS Rotorua GP CME 9 June 2012 Dr Kingsley Nirmalaraj FRACP Endocrinologist, BOPDHB & Suite 9, Promed House, Tenth Ave, Tauranga Linda

More information

DIABETES. Mary Bruskewitz APNP, MS, BC-ADM Clinical Nurse Specialist Diabetes. November 2013

DIABETES. Mary Bruskewitz APNP, MS, BC-ADM Clinical Nurse Specialist Diabetes. November 2013 DIABETES Mary Bruskewitz APNP, MS, BC-ADM Clinical Nurse Specialist Diabetes November 2013 mbruskewitz@outlook.com Objectives Part 1 Overview of Endocrine Physiology Pathophysiology of Diabetes Diabetes

More information

Canadian Agency for Drugs and Technologies in Health. Canadian Optimal Medication Prescribing & Utilization Services

Canadian Agency for Drugs and Technologies in Health. Canadian Optimal Medication Prescribing & Utilization Services Canadian Agency for Drugs and Technologies in Health Canadian Optimal Medication Prescribing & Utilization Services [DRAFT] Long-acting insulin analogues for the treatment of diabetes mellitus: meta-analyses

More information

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section. TITLE TREATMENT OF HYPOGLYCEMIA - ADULT SCOPE Provincial: Acute Care APPROVAL AUTHORITY Clinical Operations Executive Committee SPONSOR Diabetes, Obesity and Nutrition Strategic Clinical Network PARENT

More information

What do you need to know before you go home?

What do you need to know before you go home? What do you need to know before you go home? What is Insulin Types of Insulin Injection Sites How to Inject Insulin Correctly Low Blood Sugar and Treatment Sick Day Management After leaving the Hospital:

More information

Advanced Practice Education Associates. Endocrine

Advanced Practice Education Associates. Endocrine Advanced Practice Education Associates Endocrine Overview Diabetes Thyroid Disease 162 Copyright 2016 Advanced Practice Education Associates DIABETES MELLITUS What is the BMI cut point for screening adults

More information

Clinical Practice Guidelines

Clinical Practice Guidelines Clinical Practice Guidelines Diabetes Objective The purpose is to guide the appropriate diagnosis and management of Diabetes. This guideline is designed to assist the clinician by providing a framework

More information

Why do we care? 20.8 million people. 70% of people with diabetes will die of cardiovascular disease. What is Diabetes?

Why do we care? 20.8 million people. 70% of people with diabetes will die of cardiovascular disease. What is Diabetes? What is Diabetes? Diabetes 101 Ginny Burns RN MEd CDE Diabetes mellitus is a group of diseases characterized by high levels of blood glucose resulting from defects in insulin production, insulin action

More information

Common Diabetes-related Terms

Common Diabetes-related Terms Common Diabetes-related Terms A1C An A1C test measures a person's average blood glucose level over two to three months. Hemoglobin is the part of a red blood cell that carries oxygen to the cells and sometimes

More information

Providing Stability to an Unstable Disease

Providing Stability to an Unstable Disease Basal Insulin Therapy Providing Stability to an Unstable Disease Thomas A. Hughes, M.D. Professor of Medicine - Retired Division of Endocrinology, Metabolism, and Diabetes University of Tennessee Health

More information

Oral and Injectable Medication Options for Diabetes Treatment

Oral and Injectable Medication Options for Diabetes Treatment Oral and Injectable Medication Options for Diabetes Treatment Presented by: Dr. Daphne E. Smith, Pharm.D., CDE Clinical Assistant Professor/Clinical Pharmacist-University of Illinois at Chicago College

More information

Management of Type 2 Diabetes Mellitus. Heather Corn, MD, MS Endocrinology, Diabetes, and Metabolism

Management of Type 2 Diabetes Mellitus. Heather Corn, MD, MS Endocrinology, Diabetes, and Metabolism Management of Type 2 Diabetes Mellitus Heather Corn, MD, MS Endocrinology, Diabetes, and Metabolism Disclosures Working for Intermountain Healthcare Some of the views represented are the opinion of ABIM-certified

More information

Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols. Askiel Bruno, MD, MS Protocol PI

Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols. Askiel Bruno, MD, MS Protocol PI Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols Askiel Bruno, MD, MS Protocol PI SHINE Synopsis Acute ischemic stroke

More information

INSULIN 101: When, How and What

INSULIN 101: When, How and What INSULIN 101: When, How and What Alice YY Cheng @AliceYYCheng Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form

More information

Basal-Bolus Insulin Therapy. Veronica Brady, PhD, FNP-BC, BC-ADM, CDE ECHO January

Basal-Bolus Insulin Therapy. Veronica Brady, PhD, FNP-BC, BC-ADM, CDE ECHO January Basal-Bolus Insulin Therapy Veronica Brady, PhD, FNP-BC, BC-ADM, CDE ECHO January 18 2018 Terminology No longer using the term diabetic. Diabetes does not define people. People with diabetes are individuals

More information

Volume 2; Number 14 September 2008 NICE CLINICAL GUIDELINE 66: TYPE 2 DIABETES THE MANAGEMENT OF TYPE 2 DIABETES (MAY 2008)

Volume 2; Number 14 September 2008 NICE CLINICAL GUIDELINE 66: TYPE 2 DIABETES THE MANAGEMENT OF TYPE 2 DIABETES (MAY 2008) Volume 2; Number 14 September 2008 NICE CLINICAL GUIDELINE 66: TYPE 2 DIABETES THE MANAGEMENT OF TYPE 2 DIABETES (MAY 2008) The purpose of this special edition of the PACE Bulletin is to summarize the

More information

1,2,3 1. Diabetes in the Latino Population: A Case-based Approach to Optimal Management. Why Are We Concerned about Diabetes Among Latinos?

1,2,3 1. Diabetes in the Latino Population: A Case-based Approach to Optimal Management. Why Are We Concerned about Diabetes Among Latinos? Diabetes in the Latino Population: A Case-based Approach to Optimal Management 1 Learner Objectives Upon completion, attendees should be able to: List the medical, social, and economic ways in which diabetes

More information

Questions may not always match the order of those online. Please be sure to read the questions when completing the online test.

Questions may not always match the order of those online. Please be sure to read the questions when completing the online test. Module 13 Part 1 Questions may not always match the order of those online. Please Case #1 Fred W. Fred W. is in to see you for a referral from his family physician. In the referral letter, the family physician

More information

Diabetes Mellitus II CPG

Diabetes Mellitus II CPG 1 Diabetes Mellitus II CPG Candidates for Screening Integrated Complex Care Patients: Check Yearly Prediabetes: Check Yearly No Diabetes Mellitus (DM) Risk Factors: Check at Age 45, Repeat Every 3 Years

More information

Age-adjusted Percentage of U.S. Adults Who Were Obese or Who Had Diagnosed Diabetes

Age-adjusted Percentage of U.S. Adults Who Were Obese or Who Had Diagnosed Diabetes Age-adjusted Percentage of U.S. Adults Who Were Obese or Who Had Diagnosed Diabetes Obesity (BMI 30 kg/m 2 ) 1994 2000 2009 No Data 26.0% Diabetes 1994 2000 2009

More information

Endo 2 SLO Practice (online) Page 1 of 7

Endo 2 SLO Practice (online) Page 1 of 7 Endo 2 SLO Practice (online) Page 1 of 7 1. A long- acting insulin, like Lantus is for? A. When the next meal is within 30-60 minutes of the injection B. Over night use or for ½ of the day often combined

More information

Diabetes: Assessing your risk

Diabetes: Assessing your risk Diabetes: Assessing your risk What is diabetes? There are 2 types of diabetes. Type 1 diabetes occurs when the body does not make a hormone called insulin. Insulin helps the body use sugar (also called

More information

Guide to Starting and Adjusting Insulin for Type 2 Diabetes*

Guide to Starting and Adjusting Insulin for Type 2 Diabetes* Guide to Starting and Adjusting Insulin for Type 2 Diabetes* www.cadth.ca * Adapted from Guide to Starting and Adjusting Insulin for Type 2 Diabetes, 2008 International Diabetes Center, Minneapolis, MN.

More information

Case Study: Competitive exercise

Case Study: Competitive exercise Case Study: Competitive exercise 32 year-old cyclist Type 1 diabetes since age 15 Last HbA1 54 No complications and hypo aware On Humalog 8/8/8 and Levemir 15 Complains about significant hypoglycaemia

More information

Prior to making any insulin adjustments the following knowledge and skills are required:

Prior to making any insulin adjustments the following knowledge and skills are required: Diabetes Control Diabetes Control Food, activity and insulin influence your blood glucose levels. At times it may seem like a juggling act as you attempt to balance these three factors. Home blood glucose

More information

Nph insulin conversion to lantus

Nph insulin conversion to lantus Nph insulin conversion to lantus Search 26-2-2003 RESPONSE FROM AVENTIS. We appreciate the opportunity to respond to Dr. Grajower s request for information regarding Lantus ( insulin glargine [rdna origin.

More information

Lantus to levemir conversion

Lantus to levemir conversion Lantus to levemir conversion The Borg System is 100 % Lantus to levemir conversion 16-6-2005 Ask the Expert on... Lantus Conversion. Karen Shapiro, PharmD, BCPS. Disclosures. June 16, 2005. Question. Would

More information